DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.

MLA

Azizgolshani, Nasim, et al. “DNA 5-Hydroxymethylcytosine in Pediatric Central Nervous System Tumors May Impact Tumor Classification and Is a Positive Prognostic Marker.” Clinical Epigenetics, vol. 13, no. 1, Sept. 2021, p. 176. EBSCOhost, https://doi.org/10.1186/s13148-021-01156-9.

APA

Azizgolshani, N., Petersen, C. L., Chen, Y., Levy, J. J., Salas, L. A., Perreard, L., Nguyen, L. N., & Christensen, B. C. (2021). DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker. Clinical Epigenetics, 13(1), 176. https://doi.org/10.1186/s13148-021-01156-9

Chicago

Azizgolshani, Nasim, Curtis L Petersen, Youdinghuan Chen, Joshua J Levy, Lucas A Salas, Laurent Perreard, Lananh N Nguyen, and Brock C Christensen. 2021. “DNA 5-Hydroxymethylcytosine in Pediatric Central Nervous System Tumors May Impact Tumor Classification and Is a Positive Prognostic Marker.” Clinical Epigenetics 13 (1): 176. doi:10.1186/s13148-021-01156-9.